2 days ago
Indianapolis, IN, USASenior
Responsibilities
- Lead machine-learning and computer-vision work for R&D programs involving target identification, molecular optimization, in vitro analysis, ADMET, biomarkers, and related scientific questions.
- Design, build, and validate CNNs, transformers, graph neural networks, generative models, and other ML/CV systems on multimodal scientific data.
- Collaborate with experimental teams on data-capture protocols, annotation standards, quality checks, synthetic data, and augmentation.
- Deploy models in R&D workflows, including using Databricks, and influence standards for reproducibility, documentation, monitoring, and model governance.
- Lead cross-functional modeling initiatives, mentor junior scientists, and communicate technical concepts and results to diverse stakeholders.
Requirements
- PhD in a quantitative field or a master's degree with substantial hands-on machine-learning and computer-vision experience.
- At least 7 years of industry experience building and deploying ML/CV models for scientific problems in biomedical, pharmaceutical, or related domains.
- Strong Python skills and proficiency with modern ML/CV libraries such as PyTorch, TensorFlow, scikit-learn, and OpenCV.
- Solid understanding of statistics and experimental design, with effective communication and collaboration skills in cross-functional, matrixed environments.
- Preferred qualifications include animal-health, pharmaceutical, or biotech R&D experience; impactful chemoinformatics, bioinformatics, or digital-biomarker work; generative-model expertise; Databricks and MLOps experience; and experience leading teams or mentoring junior scientists.
Benefits
- Comprehensive benefits supporting financial, physical, and mental well-being.
- Multiple relocation packages and flexible work arrangements.
- Two weeklong US shutdowns in mid-summer and at year-end in addition to PTO.
- Eight-week parental leave.
- Nine Employee Resource Groups.
- Annual bonus offering.
- Up to 6% 401(k) matching.
- Indianapolis, Indiana location with up to 10% travel.
Categories
About Elanco
Elanco is a public animal health company that develops pharmaceuticals, vaccines, parasiticides, and nutrition products for pets and farm animals, sold through veterinarians, distributors, and retail channels. Headquartered in Indianapolis and traded on the NYSE (ELAN), it originated at Eli Lilly in 1954 and became an independent company in 2018. Elanco expanded its portfolio by acquiring Bayer Animal Health in 2020, serving companion-animal and livestock markets worldwide.